{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:01:59Z","timestamp":1768579319778,"version":"3.49.0"},"reference-count":30,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Stroke is currently the second most common cause of death and disability-adjusted life years worldwide. Previous studies have determined that cardioembolic stroke is associated with higher mortality. Our aim is to compare the long-term outcome and mortality of atherothrombotic, cardioembolic stroke patients and patients taking direct oral anticoagulants (DOACs), and to demonstrate that adequate treatment with DOACs is associated with better results. Materials and Methods: In our retrospective study, we collected the data of ischemic stroke patients who were treated at P. Stradins Clinical University Hospital, Riga, Latvia, Stroke Unit, in the year 2017. In the present study, we analyzed this information to assess the patients\u2019 demographic and clinical data, vascular risk factors, functional and neurological evaluation results, and the use of anticoagulant therapy. Stroke survivors were followed-up via telephone at 30\/90\/180\/365 days and 4 years after being discharged from the hospital. The Latvian version of the National Institutes of Health Stroke Scale (NIHSS-LV) was used to evaluate patients\u2019 neurological outcomes at discharge, and patients\u2019 functional outcomes were evaluated using the modified Rankin scale (mRS). The collected data of the patients were separated into three groups according to the stroke subtype and use of direct oral anticoagulants. Results: A total of 654 ischemic stroke patients were admitted to the hospital in the year 2017. Of all the strokes included in the study, 262 presented an atherothrombotic etiology and 392 presented a cardioembolic etiology. The median age of the patients in the study was 76 years (IQR: 67\u201383). The median age of patients in the atherothrombotic stroke group was 71 years (IQR = 64\u201379), in the cardioembolic stroke group it was 79 (IQR = 72\u201384), and in the DOAC group it was 75 years (IQR = 69\u201382), respectively. At the period of four years, of all the atherothrombotic stroke survivors 14 (10.5%) had a severe disability, and 64 (48.1%) did not survive. However, 12 (4.1%) of the cardioembolic stroke survivors were severely disabled and 37 (12.5%) had died. In the group of patients taking DOACs 6 (4.5%) had a severe disability and 17 (12.9%) did not survive. In all the patient groups, the leading cause of death was due to severe disability (22%), followed by recurrent cardioembolic events (8%). Conclusions: Previous studies until now have concluded that cardioembolic stroke is associated with higher mortality and an unfavorable functional outcome. In our study, the cardioembolic stroke group and the DOAC group had a statistically significant higher percentage of patients with congestive heart failure and older age, but their long-term mortality was lower and they achieved independence more often than the atherothrombotic stroke patients. The proper use of anticoagulants shows great improvement in long-term survival rate and functional outcome.<\/jats:p>","DOI":"10.3390\/medicina58101323","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T01:47:06Z","timestamp":1663811226000},"page":"1323","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of Anticoagulants in Reducing Mortality and Disability in Cardioembolic Stroke Patients"],"prefix":"10.3390","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1730-8354","authenticated-orcid":false,"given":"Kristaps","family":"Jurj\u0101ns","sequence":"first","affiliation":[{"name":"Department of Neurology and Neurosurgery, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia"},{"name":"Department of Doctoral Studies, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia"},{"name":"Department of Neurology, Pauls Stradins Clinical University Hospital, 13 Pilsonu Street, LV-1002 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"C\u0113rpa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Pauls Stradins Clinical University Hospital, 13 Pilsonu Street, LV-1002 Riga, Latvia"},{"name":"Faculty of Continuing Education, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alise","family":"Baborikina","sequence":"additional","affiliation":[{"name":"Department of Neurology, Pauls Stradins Clinical University Hospital, 13 Pilsonu Street, LV-1002 Riga, Latvia"},{"name":"Faculty of Continuing Education, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5919-4995","authenticated-orcid":false,"given":"Oskars","family":"Kal\u0113js","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia"},{"name":"Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, 13 Pilsonu Street, LV-1002 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4862-6726","authenticated-orcid":false,"given":"Evija","family":"Migl\u0101ne","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurosurgery, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia"},{"name":"Department of Neurology, Pauls Stradins Clinical University Hospital, 13 Pilsonu Street, LV-1002 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"key":"ref_1","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators (2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388, 1459\u20131544. Erratum in Lancet 2017, 389, e1."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2174\/157340310791658730","article-title":"Cardioembolic Stroke: Clinical Features, Specific Cardiac Disorders and Prognosis","volume":"6","author":"Arboix","year":"2010","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00415-003-1017-0","article-title":"Brain embolism\u2014Answers to practical questions","volume":"250","author":"Ferro","year":"2003","journal-title":"J. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000319048","article-title":"Symptomatic Hemorrhagic Transformation and Its Predictors in Acute Ischemic Stroke with Atrial Fibrillation","volume":"64","author":"Lee","year":"2010","journal-title":"Eur. Neurol."},{"key":"ref_5","first-page":"81","article-title":"Hemorrhagic transformation after cerebral infarction: Current concepts and challenges","volume":"2","author":"Zhang","year":"2014","journal-title":"Ann. Transl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/WNL.41.6.837","article-title":"Early spontaneous hematoma in cerebral infarct: Is primary cerebral hemorrhage overdiagnosed?","volume":"41","author":"Bogousslavsky","year":"1991","journal-title":"Neurology"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Masili\u016bnas, R., Dapkut\u0117, A., Grigait\u0117, J., Lap\u0117, J., Valan\u010dius, D., Bacevi\u010dius, J., Katkus, R., Vilionskis, A., Klima\u0161auskien\u0117, A., and Ekkert, A. (2022). High Prevalence of Atrial Fibrillation in a Lithuanian Stroke Patient Cohort. Medicina, 58.","DOI":"10.3390\/medicina58060800"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Jurjans, K., Vikmane, B., Vetra, J., Miglane, E., Kalejs, O., Priede, Z., and Millers, A. (2019). Is Anticoagulation Necessary for Severely Disabled Cardioembolic Stroke Survivors?. Medicina, 55.","DOI":"10.3390\/medicina55090586"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e01152","DOI":"10.1002\/brb3.1152","article-title":"Factors associated with long-term mortality for stroke unit patients in Latvia","volume":"8","author":"Mihejeva","year":"2018","journal-title":"Brain Behav."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1177\/0300060516664636","article-title":"The adaption and evaluation of a Latvian version of the National Institutes of Health Stroke Scale","volume":"45","author":"Noviks","year":"2017","journal-title":"J. Int. Med. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.030","article-title":"The Rankin Focused Assessment-Ambulation: A Method to Score the Modified Rankin Scale with Emphasis on Walking Ability","volume":"25","author":"Patel","year":"2016","journal-title":"J. Stroke Cereb. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1161\/01.STR.30.8.1538","article-title":"Use of the Barthel Index and Modified Rankin Scale in Acute Stroke Trials","volume":"30","author":"Sulter","year":"1999","journal-title":"Stroke"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/ane.13201","article-title":"TOAST classification and risk factors of ischemic stroke in Lebanon","volume":"141","author":"Malek","year":"2020","journal-title":"Acta Neurol. Scand."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/svn-2018-000143","article-title":"Cardioembolic stroke: Everything has changed","volume":"3","author":"Spence","year":"2018","journal-title":"Stroke Vasc. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Karelis, G., Micule, M., Klavina, E., Haritoncenko, I., Kikule, I., Tilgale, B., and Polaka, I. (2021). The Riga East University Hospital Stroke Registry\u2014An Analysis of 4915 Consecutive Patients with Acute Stroke. Medicina, 57.","DOI":"10.3390\/medicina57060632"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1161\/STROKEAHA.119.026299","article-title":"Collateral Circulation and Outcome in Atherosclerotic Versus Cardioembolic Cerebral Large Vessel Occlusion","volume":"50","author":"Guglielmi","year":"2019","journal-title":"Stroke"},{"key":"ref_18","first-page":"023","article-title":"Cardioembolic Stroke: Risk Factors, Clinical Features, and Early Outcome in 956 Consecutive Patients","volume":"73","author":"Arboix","year":"2020","journal-title":"Rev. Investg. Clin."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lawrence, M., Pringle, J., Kerr, S., Booth, J., Govan, L., and Roberts, N.J. (2015). Multimodal Secondary Prevention Behavioral Interventions for TIA and Stroke: A Systematic Review and Meta-Analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120902"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/STROKEAHA.115.011595","article-title":"Different Antiplatelet Strategies in Patients With New Ischemic Stroke While Taking Aspirin","volume":"47","author":"Kim","year":"2016","journal-title":"Stroke"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1161\/01.STR.0000222978.96083.d9","article-title":"Classification of Cause of Death After Stroke in Clinical Research","volume":"37","author":"Halkes","year":"2006","journal-title":"Stroke"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/STROKEAHA.118.022253","article-title":"Large Vessel Occlusion in Acute Stroke","volume":"49","author":"Beume","year":"2018","journal-title":"Stroke"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"651387","DOI":"10.3389\/fneur.2021.651387","article-title":"Decomposing Acute Symptom Severity in Large Vessel Occlusion Stroke: Association With Multiparametric CT Imaging and Clinical Parameters","volume":"12","author":"Stueckelschweiger","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_24","first-page":"280","article-title":"Oral anticoagulant use among patients hospitalized with stroke in riga east clinical university hospital","volume":"22","author":"Zigure","year":"2018","journal-title":"Neurol. Semin."},{"key":"ref_25","first-page":"106","article-title":"Dyslipidemia and outcome in patients with acute ischemic stroke","volume":"27","author":"Xu","year":"2014","journal-title":"Biomed. Environ. Sci."},{"key":"ref_26","first-page":"e25880","article-title":"Prevalence of Dyslipidemia in Ischemic Stroke Patients: A Single-Center Prospective Study From Pakistan","volume":"14","author":"Khan","year":"2022","journal-title":"Cureus"},{"key":"ref_27","first-page":"345","article-title":"Effect of dyslipidemia on severity and outcome of stroke using mRS scores in Northern Pakistani population","volume":"38","author":"Sohail","year":"2013","journal-title":"Rawal Med. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1161\/01.STR.0000102171.91292.DC","article-title":"Cholesterol and the Risk of Ischemic Stroke","volume":"34","author":"Bowman","year":"2003","journal-title":"Stroke"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/neurolint14020032","article-title":"Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities","volume":"14","author":"Chavda","year":"2022","journal-title":"Neurol. Int."},{"key":"ref_30","first-page":"97","article-title":"Ictus isqu\u00e9mico por oclusi\u00f3n de la arteria basilar en una paciente pu\u00e9rpera con infecci\u00f3n por SARS-CoV-2 [Ischaemic stroke due to basilar artery occlusion in a puerperal patient with SARS-CoV-2 infection]","volume":"75","author":"Puchades","year":"2022","journal-title":"Rev Neurol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/10\/1323\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:36:40Z","timestamp":1760143000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/10\/1323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["medicina58101323"],"URL":"https:\/\/doi.org\/10.3390\/medicina58101323","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,21]]}}}